Clinical Trial: Build a multimodal big data platform and a multi-omics high-throughput detection system to screen and validate the efficacy and toxicity biomarkers of radioimmunotherapy combined with other treatments (China)

Posted On: 2026-08-18

China, Aug. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Build a multimodal big data platform and a multi-omics high-throughput detection system to screen and validate the efficacy and toxicity biomarkers of radioimmunotherapy combined with other treatments'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130202

Registration Time: 2026/08/17

Type: Interventional study

Primary Sponsor: Sun Yat-sen University Cancer Center (Sun Yat-sen University Affiliated Cancer Hospital, Sun Yat-sen University Cancer Research Institute)

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=323826

Published by HT Digital Content S...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Build a multimodal big data platform and a multi-omics high-throughput detection system to screen and validate the efficacy and toxicity biomarkers of radioimmunotherapy combined with other treatments (China)